Trial intelligence / Profile preview

Cerebrolysin in Acute Ischemic Stroke

NCT02581371Phase 4Unknown

Start
Feb 2015
Primary completion
Feb 2017
Modality
Native Peptides
Countries
1
01

Overview

A Phase 4 trial of cerebrolysin in ischemic stroke. Status: unknown.

02

Drugs

cerebrolysin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02581371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02581371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call